Market Tracker

03/30 8:19am ET

Shire PLC (NASDAQ:SHPG)

178.19
Delayed Data
As of Mar 29
 +0.79 / +0.45%
Today’s Change
161.09
Today|||52-Week Range
209.22
+4.58%
Year-to-Date
Shire (SHPG) Rare Disease Drug Gets Fast Track Designation
Mar 23 / Zacks.com - Paid Partner Content
Shire's (SHPG) Cinryze Label Expanded for Pediatric Use
Mar 16 / Zacks.com - Paid Partner Content
Is Shire Stock a Good Choice for Value Investors Now?
Mar 21 / Zacks.com - Paid Partner Content
Keryx Focuses on Kidney Drug Aurexia Despite Generic Threat
Mar 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close177.40
Today’s open176.21
Day’s range176.16 - 178.50
Volume833,943
Average volume (3 months)1,021,482
Market cap$53.8B
Dividend yield0.51%
Data as of 03/29/2017

Growth & Valuation

Earnings growth (last year)-80.61%
Earnings growth (this year)+14.92%
Earnings growth (next 5 years)+12.30%
Revenue growth (last year)+76.71%
P/E ratio77.1
Price/Sales3.89
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
REGNRegeneron Pharmaceut...+11.59+3.03%
NVONovo Nordisk+0.08+0.23%
ABTAbbott Laboratories-0.03-0.07%
INCYIncyte Corp-0.20-0.14%
Data as of 03/29/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$3.47
Annual revenue (last year)$11.3B
Annual profit (last year)$325.1M
Net profit margin5.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts